Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells

International Journal of Cancer

Volumn 104, Issue 2, 2003, Pages 155-160

  Mitropoulou, Theoni N ^a   Tzanakakis, George N ^b   Kletsas, Dimitris ^c   Kalofonos, Haralabos P ^d   Karamanos, Nikos K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

^c Institute of Biology   (Greece)

^d UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Breast cancer; Invasion and metastasis; Letrozole; Metalloproteinases

Indexed keywords

ANDROSTENEDIONE; ANTIMITOTIC AGENT; AROMATASE; ESTRADIOL; ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; LETROZOLE; METALLOPROTEINASE; TESTOSTERONE;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INVASION; CATALYSIS; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 12A; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA ISOLATION; TUMOR GROWTH;

BREAST NEOPLASMS; CELL DIVISION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HORMONES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NITRILES; RNA, MESSENGER; TRIAZOLES; TUMOR CELLS, CULTURED;

EID: 0344951288     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10941     Document Type: Article

References (50)

1. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88:1571-9.
2. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
3. Armstrong PB, Armstrong MT. Intercellular invasion and the organizational stability of tissues: a role for fibronectin. Biochim Biophys Acta 2000;1470:9-20.
4. Woodhouse AC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997;suppl 80:1529-37.
5. Brown PD. Matrix metalloproteinase inhibitors. Breast Cancer Res Treat 1998;52:125-36.
6. Nakajima M, Welsch DR, Belloni PN, Nicolson GL. Degradation of basement embrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987;47:4869-76.
7. Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907: 191-217.
8. Liotta LA, Stetler-Stevenson WG. Metalloproteases and cancer invasion. Semin Cancer Biol 1990;99:99-106.
9. r 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT 1080 tumor cells. Cancer Res 1990;50:6162-70.
10. Lochter A, Bissell MJ. Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol 1995;6:165-73.
11. Jones PL, Schmidhauser C, Bissell MJ. Regulation of gene expression and cell function by extracellular matrix. Crit Rev Eukaryotic Gene Expr 1993;3:137-54.
12. Quinn LA, Burak Jr WE, Brueggemeier RW. Effects of matrix components on aromatase activity in breast stromal cells in culture. J Steroid Biochem Mol Biol 1999;70:249-56.
13. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002;62:283-9.
14. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 1996; 81:1460-4.
15. Esteban JM, Warsi Z, Haniu M, Hall PF, Shively JE, Chen S. Detection of intratumoral aromatase in breast carcinomas, an immunohistochemical study with clinicopathologic correlation. Am J Pathol 1992;140:337-43.
16. Santen RJ, Martel J, Hoagland M, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Santner SJ. Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 1994;79:627-32.
17. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 1994;25:530-5.
18. Lu Q, Nakamura J, Savinov A, Yue W, Weisz J, Dabbs DJ, Wolz G, Brodie A. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 1996;137:3061-77.
19. Santen RJ, Santner SJ, Pauley RJ, Tait L, Kaseta J, Demers LM, Hamilton C, Yue W, Wang JP. Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible? J Steroid Biochem Mol Biol 1997;61:267-71.
20. Chen D, Zhou D, Okubo T, Kao Y-C, Yang C. Breast tumor aromatase: functional role and transcriptional regulation. Endocr Relat Cancer 1999;6:149-56.
21. Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE. Influence of letrozole and anastrazole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 2002;20:751-7.
22. Zhou D, Wang J, Chen E, Murai J, Siiteri PK, Chen S. Aromatase gene is amplified in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 1993;46:147-53.
23. Kitawaki J, Fukuoka M, Yamamoto T, Honjo H, Okada H. Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors. J Steroid Biochem Mol Biol 1992;42:267-77.
24. Burak WE Jr, Quinn LA, Farrar WB, Brueggemeier RW. Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase. Breast Cancer Res Treat 1997; 44:57-64.
25. Hamilton A, Volm M. Nonsteroidal and steroidal aromatase inhibitors in breast cancer. Oncology (Huntingt) 2001;15:965-72.
26. Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, Apffelstaedt J, Smith R, Sleeboom HP, Janicke F, Pluzanska A, Dank M, et al. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer. Results of phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001;19:2596-606.
27. Pritchard KI. The role of tamoxifen and aromatase inhibitors/inactivators in postmenopausal patients. Clin Cancer Res 2001;7:4356s-9s.
28. Cohen MH, Johnson JR, Li N, Chen G, Pazdur R. Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer. Clin Cancer Res 2002;8:665-9.
29. Corbin C, Graham-Lorence S, McPhaul M, Mason J, Mendelson C, Simpson E. Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 1988;85:8948-52.
30. Dobra K, Andang M, Syrokou A, Karamanos NK, Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp Cell Res 2000;258:12-22.
31. Kletsas D, Stathakos D, Sorrentino V, Philipson L. The growth-inhibitory block of TGF-β is located close to the G1/S border in the cell cycle. Exp Cell Res 1995;217:477-83.
32. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976;36:4595-601.
33. Pasqualini JR, Chetrite G. Paradoxical effect of estradiol: it can block its own bioformation in human breast cancer cells. J Steroid Biochem Mol Biol 2001;78:21-4.
34. Tan L, Muto N. Purification and reconstitution properties of human placental aromatase: cytochrome P-450-type mono-oxygenase. Eur J Biochem 1986;156:243-50.
35. Lephart ED, Simpson ER. Assay of aromatase activity. Methods Enzymol 1991;206:477-83.
36. Brodie AMH, Wing LY, Goss P, Dowsett M, Coombes RC. Aromatase inhibitors and their potential clinical significance. J Steroid Biochem 1986;25:859-65.
37. Dombernowsky P, Smith I, Falkson G, Leonard R, Panasci L, Bellmunt J, Bezwoda W, Gardin G, Gudgeon A, Morgan M, Fornasiero A, Hoffmann W, et al. Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. J Clin Oncol 1998;16:453-61.
38. Varela RM, Dao TL. Estrogen synthesis and estradiol binding by human mammary tumors. Cancer Res 1978;38:2429-33.
39. Lipton A, Santner SJ, Santen RJ, Harvey HA, Feil PD, White-Hershey D, Bartholomew MJ, Antle CE. Aromatase activity in primary and metastatic human breast cancer. Cancer 1987;59:779-82.
40. Bezwoda WR, Mansoor N, Dansey R, Esser JD. Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. Oncology 1987;44:30-3.
41. Silva MC, Rowlands MG, Dowsett M, Gusterson B, McKinna JA, Fryatt I, Coombes RC. Intratumoral aromatase as a prognostic factor in human breast cancer. Cancer Res 1989;49:2588-91.
42. Miller WR, Anderson TJ, Jack WJL. Relationship between tumour aromatase activity, tumour characteristics, and response to therapy. J Steroid Biochem Mol Biol 1990;37:1055-9.
43. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Cecil H. Aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994;15:342-55.
44. Brueggemeier RW, Katlic NE. Effects of the aromatase inhibitor 7α-(4′-amino)phenylthio-4-3,17-dione in MCF-7 human mammary carcinoma cell culture. Cancer Res 1987;47:4548-51.
45. Brueggemeier RW, Katlic NE. Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cells. Cancer Res 1990;50:3652-6.
46. Dowsett M, Macauley V, Gledhill J, Ryde C, Nicholls J, Ashworth A, McKinna JA, Smith IE. Control of aromatase in breast cancer cells and its importance for tumor growth. J Steroid Biochem Mol Biol 1993;44:605-9.
47. Sadekova SI, Tan L, Chow TYK. Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7. Anticancer Res 1994; 14:507-12.
48. Macaulay VM, Nicholls JE, Gledhill J, Rowlands MG. Dowsett M, Ashworth A. Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br J Cancer 1994; 69:77-83.
49. Abbas Abidi SM, Howard EW, Dmytryk JJ, Thomas Pent J. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells. Clin Exp Metastasis 1997;15:432-9.
50. Rha SY, Yang WI, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Chung HC. Different expression patterns of MMP-2 and MMP-9 in breast cancer. Oncol Rep 1998;5:875-9.